Ever notice that good clinics do not have to talk about and/or send out announcements of “how good they are or how high their success rates are”? ACFS believes this is simply done by reputation and word of mouth that is backed up by accurate and reproducible results over and over again. If you are good at what you do, you do not have to say it; your patients and results will for you.
When the older technologies for chromosome testing using FISH where replaced by the newer technologies of PCR and 23-Chromosome Microarray, Arizona Center for Fertility Studies realized early on that this technology would be a very important key to the improved success of IVF and would result in higher success rates and lower miscarriage rates. This journey started about 7 years ago and ACFS was one of the first clinics in the US to “see” the true value of chromosome testing or PGS (preimplantation genetic screening). We subsequently began to offer PGS to all our patients doing IVF. Although, truly revolutionary in producing better outcomes, it was early criticized as “not making a difference in IVF outcomes and would damage the embryo”. Early PGS was done on day 3 embryos using weak acids to dissolve the egg’s outer wall or zona pellucida. Early on, these techniques concerned us at ACFS; and although we never damaged a single embryo, the use of a weak acid anywhere near the embryo was worrisome.
But something much bigger changed our minds in how this new technology should be used. First, ACFS was driven to be successful on each patient’s first attempt at IVF (for many obvious reasons). Second, we had a number of biopsied day 3 embryos that made “beautiful” day 5 embryos or blastocysts but came back chromosomally abnormal. There had been speculation that embryos could “self-correct” but there was no scientific proof of that. With patients’ permission and informed consent, ACFS asked to re-biopsy these abnormal day 5 blastocysts to see what percentage of them, if any, had “self-corrected”. In collaboration with 3 other clinics we found that in the first 24 day 5-6 embryos re-biopsied, 64% had “self-corrected” and were read as normal. ACFS, along with 3 other major clinics, published what we believed at the time to be the first scientific paper showing the embryos could “self-correct” by day 5-6 of development. That was the last time ACFS did day 3 embryo biopsies. However, this change demanded and pushed ACFS to get proficient with culturing embryos out to the blastocyst stage, using the new and expensive laser technology to biopsy day 5-6 embryos, replacing the use of weak acids (thank god).
Since PGS results could take up to a week to get back, ACFS needed to get proficient in embryo freezing or vitrification. This actually worked to ACFS advantage because we were starting to realize that frozen embryo transfers (FET) were showing up to 30% higher pregnancy rates and significantly reduced the risks of ovarian hyperstimulation syndrome (OHSS) allowing ACFS to use more aggressive stimulation protocols that proved instrumental in recovering increased quality and quantity of eggs with resulting higher numbers of “quality” embryos for transfer and more remaining to cryopreserve.
The above chart shows the inefficiency of human reproduction and thus supports ACFS findings and experience of “improving” the odds with 23-Chromosome Microarray or PGS testing on all patients undergoing IVF
Courtesy of Richard Scott looking at 132,874 mature follicles and Genesis Genetics
But there was one very big problem. Like FISH before it, 23-Chromosome Microarray testing was expensive, in the neighborhood of $6000-7000 and most patients, although very clear of its benefits, could not afford the cost on top of the already expensive IVF procedure. Well, how did you get people to do what you think is important? Easy, make it worth their while. In an unprecedented decision, over 5+ years ago, ACFS decided to charge cost for PGS testing; and as far as we know, we are the only IVF clinic in the United States to do so. In other words, ACFS “does not make a dime” on chromosome testing or PGS. Actually, we make less money because on the outside chance there are no embryos to transfer, we do charge or collect the transfer fee. Sometimes there are normal embryos to transfer but there are no remaining normal ones to cryopreserve so we lose our freezing and storage fees. ACFS does charge for freezing day 5-6 embryos after undergoing PGS biopsy. They are frozen at no charge. The only freezing charges come if there are extra normal embryos after the FET or frozen embryo transfer (which, of course, is a good thing because it gives a couple future attempts to have more children without going through the entire process again and thus saves a significant amount of time, money and emotions and having chromosome normal embryos from when they were younger).
With ACFS success rates, this decision to do PGS at cost did not make any “business” sense. We could charge “what we wanted”; and unfortunately, most clinics do and they do not have anywhere near the same success rates as us. There was only one thing in the way. A promise ACFS made at its inception in 1982 - a strong and undying commitment to helping couples achieve their most cherished dreams - a baby. A promise and commitment to have kept for over 30 years. It is ACFS very strong believe, that if you had something that good, you need to “give it away”. And still many clinics say that PGS does not “really” make a difference in overall outcomes and the procedure “might“ damage the embryo. Sorry, but that’s code for we don’t do it for a myriad of reasons I think you can probably figure out. ACFS, respectfully, could not forcibly disagree more. Actually, current literature in 2015 is clearly showing that PGS “does” make a difference in not only pregnancy rates but also reducing miscarriage rates. No surprise to ACFS.
How nice would it be to find and only transfer chromosome normal embryos rather than just transferring 1-2 untested day 3 or day 5 embryos and “hoping for the best” and freezing all the remaining ones; not knowing if they were chromosomally “normal” or not. And then possibly doing multiple frozen embryo transfers or (FET) again and again “hoping” for the best and running the “real” risks of it not working (most chromosome abnormal embryos do not even implant), the “real” risk of a miscarriage (70-80% of miscarriages are due to chromosome abnormalities); or god forbid worst, the risk of a chromosome abnormality resulting in a live birth like a Down’s Syndrome baby or worst. How nice would it be for any couple, young or old, not to worry about the risk of having a chromosomally abnormal pregnancy and having to face that “so very hard” decision of whether or not to terminate or keep the pregnancy? PGS effectively eliminates all that worry.
Interesting, contrary to popular belief, the percentage of chromosome abnormalities are somewhat equally divided between all of the 23 pairs of chromosomes (each individual has 2 sets of 23 or 46 chromosomes in total with females having 46XX and males having 46XY). Common chromosome abnormalities like Down’s syndrome make up 3% of all abnormalities, Trisomy 16 (or an extra chromosome in the 16th position and the most common cause of miscarriage) accounts for 3% of abnormalities.
Percentage of Monsomies (only one chromosome instead of two) and Trisomies (third chromosomes instead of two with Trisomy 21 or Down’s being one of the most common) seen in approximately 50,000 embryo biopsies.
Courtesy of Genesis Genetics.org
The hard part for ACFS is not to get good eggs and embryos. We are very good at what we do. Respectfully, we feel that we can get “any” patient “good” eggs and embryos, not matter what their age is because we have “control” over the situation. Where we “lose” control is whether or not those eggs/embryos are chromosomally normal. If ACFS can transfer 2-day 5 chromosome normal embryos, we can give any patient, regardless of her age, an 83.3% chance of pregnancy. If we transfer one embryo, the success is 59.0%.
Book your first appointment and get your free copy of Dr. Jay S. Nemiro's groundbreaking book,